VANGUARD GROUP INC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 40 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$24,801
-2.5%
276,4910.0%0.00%
Q2 2023$25,437
-65.9%
276,491
-3.5%
0.00%
Q1 2023$74,526
-46.9%
286,638
-57.1%
0.00%
Q4 2022$140,226
-22.5%
667,740
-6.4%
0.00%
Q3 2022$181,000
-65.8%
713,129
-3.2%
0.00%
Q2 2022$530,000
-8.9%
736,9230.0%0.00%
Q1 2022$582,000
-21.0%
736,9230.0%0.00%
Q4 2021$737,000
-43.0%
736,923
-0.2%
0.00%
Q3 2021$1,292,000
-3.2%
738,361
+1.2%
0.00%
Q2 2021$1,335,000
-9.4%
729,7610.0%0.00%
Q1 2021$1,474,000
-6.1%
729,7610.0%0.00%
Q4 2020$1,569,000
-21.8%
729,761
-1.8%
0.00%
Q3 2020$2,006,000
+24.1%
743,059
+81.0%
0.00%
Q2 2020$1,617,000
+430.2%
410,510
+2.6%
0.00%
Q1 2020$305,000
+17.3%
400,078
+93.8%
0.00%
Q4 2019$260,000
+81.8%
206,4340.0%0.00%
Q3 2019$143,000
+25.4%
206,434
+14.7%
0.00%
Q2 2019$114,000179,9850.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2020
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders